In mice, a cannabinoid's anxiety effect runs partly through amygdala somatostatin neurons

Two experiments carry the finding, and they answer different questions. The imaging shows that central amygdala neurons making somatostatin, a neuropeptide that helps regulate stress responses ^[10], fire harder as the dose climbs and the freezing lengthens ^[4][3]. On its own that is a correlation. Cells that track a frightened state could be reporting it without producing it. The silencing experiment tests direction by removing the cells' output and watching what happens to behavior ^[5]. Avoidance of the predator scent fell, and ScienceAlert describes the anxiety-like response as partially quelled ^[6].

The odor puts context into the design, because the drugged mice were tested against a threat ^[2]. Sachin Patel, the Northwestern psychiatric neuroscientist who was senior author on the Nature Communications paper ^[1], interprets the result as dose and threat compounding each other. "Higher doses of cannabinoids and environmental stress worked together to synergistically release the 'brake' on the central amygdala, which in turn drove excessive anxiety," he said ^[7]. The published account does not give animal numbers or effect sizes, or say how drugged mice behaved with no odor present. That no-odor comparison is what a claim of synergy would normally rest on.

The human question turns on the compound. The mice never received THC ^[2]. THC appears in the account only as background: cannabinoids including THC were already known to act strongly on the central amygdala, a region that helps control anxiety and stress responses ^[9]. Patel connects the result to human use directly. "The results of this study could explain why a good trip can turn bad pretty quickly if people consume too much cannabis," he said, "or the situation they are in turns stressful or scary" ^[8]. ScienceAlert notes that the circuit has so far been seen operating this way only in mice ^[11].

In our view the evidence supports a narrower statement. In mice, output from these neurons carries part of a synthetic cannabinoid's amplified response to a predator cue. Patel goes further. "Suppressing the activity of somatostatin neurons in the central amygdala could represent a final pathway for reducing anxiety symptoms, not just in the context of cannabis side effects," he said ^[12]. The experiments behind that proposal used a single synthetic compound and a single predator odor, in mice ^[2].